All News

Experts say public procurement of innovation will help spur more start-ups. But a ‘bottom-up’ approach to designing EU programmes is also vital.

The Science|Business Innovation Board issues a statement backing the EU’s €80 billion R&D programme, Horizon 2020 – and seeks support from other companies and universities

Study says deployment of carbon capture and storage technology can deliver major economic benefits in the race to slash greenhouse gas emissions

The European Parliament’s Research, Industry and Energy Committee has adopted a tough negotiating position on the EU’s next research funding programme.

EU budget negotiations may be stalled, with possible consequences for future R&D funding. But at least one collaborative science project – the European Space Agency - has agreed its long-term funding

University-industry partnerships have never been more important in developing a knowledge-based economy. This makes it critical to understand the drivers and barriers to effective collaboration, says Tatiana Schofield

IEA Executive Director Maria van der Hoeven discusses how Energy efficiency and renewable energy technologies will play a vital role in the transition to a secure and sustainable energy future

UK start-up Breathing Buildings rethinks natural ventilation

MEPs reached a tentative compromise with Member States this week on the Single Patent. All that’s needed now is for EU ministers give the proposal a nod in December and for the European Parliament to vote yes too

European Medical Research Councils - along with learned societies and patients’ groups - make the case for changes to the Horizon 2020 proposals – calling for increased spending on biomedical science and the creation of a European Clinical Research Fund

Experts say cutting embryonic stem cell funding in Horizon 2020 will threaten progress Europe is making in developing safe, effective and well-regulated cell therapies - and in creating an economically important regenerative medicine sector

Europe currently leads the world in therapeutic applications of regenerative medicine. It has seen companies spin out from universities and approved products reaching the market. Science|Business brought together experts to discuss how to build on these foundations

Positive clinical data, increases in federal funding and the first regulatory approval of a manufactured stem cell product mean momentum is building in the US. With the re-election of President Obama, this is likely to continue

The EU must continue to support human embryonic stem cell research to maintain its lead in regenerative medicine. The upcoming Irish Presidency needs to recognise the importance of this research and resist calls for a ban on funding in Horizon 2020

As part of the Science|Business Special Report on stem cell research, experts give their opinion on the much debated topic